West China Hospital
Chengdu, Sichuan, 610041, China
NCT Number: NCT03322943
This study evaluates the different response of Ursodeoxycholic Acid in primary biliary cholangitis only and primary biliary cholangitis with high immune globulin G or aminotransferase at West China Hospital from 2008-2017.
Looking for future studies?
Notify Me25 year–85 year
All sexes
Observational
Chengdu, Sichuan, 610041, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients diagnosed with primary biliary cholangitis Treated with Ursodeoxycholic Acid in West China Hospital for at least 1 year
Exclusion criteria
Autoimmune hepatitis Primary sclerosing cholangitis
Time frame: up to 1 year
age,sex,ALT(IU/L),AST(IU/L),ALP(IU/L),GGT(IU/L),IgG(g/L)
Time frame: within 1 year
Use Paris II criterion to estimate
West China Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06247735
Bile Duct Diseases, Biliary Tract Diseases
Tucson, Arizona, United States
View Trial DetailsNCT04604652
Bile Duct Diseases, Bile Duct Stricture
Miami, Florida, United States
View Trial DetailsNCT05239468
Bile Duct Diseases, Biliary Tract Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT06383403
Bile Duct Diseases, Biliary Tract Diseases
Coronado, California, United States
View Trial Details